Christopher Towler
Directeur/Membre du Conseil chez OBS Medical Ltd.
Postes actifs de Christopher Towler
Sociétés | Poste | Début | Fin |
---|---|---|---|
OBS Medical Ltd.
OBS Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Christopher Towler
Anciens postes connus de Christopher Towler
Sociétés | Poste | Début | Fin |
---|---|---|---|
Oxford Spin-out Equity Management
Oxford Spin-out Equity Management Investment ManagersFinance Oxford Spin-out Equity Management (OSEM) is wholly-owned subsidiary of University of Oxford. The firm headquartered at UK. Since 2008, OSEM is responsible for spinout companies. | Directeur en chef des Investissements | 01/01/2008 | 01/07/2015 |
Private Equity Investor | 01/01/2008 | 01/07/2015 | |
Corporate Officer/Principal | 01/01/2008 | 01/07/2015 | |
Alcolizer Technology United Kingdom Ltd.
Alcolizer Technology United Kingdom Ltd. Medical DistributorsDistribution Services Alcolizer Technology United Kingdom Ltd. produces drug testing kits. It offers a device used in detecting whether a person in under the influence of specific drugs. The company was founded by Craig Edward Banks and Richard G. Compton on September 26, 2006 and is headquartered in Gateshead, the United Kingdom. | Directeur/Membre du Conseil | 04/12/2009 | 11/03/2014 |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. Celleron has deep relationships with Oxford University and is located on the Oxford Science Park. The British company focuses on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are currently in clinical trials, and they have a biomarker platform that allows them to identify responsive patients. Celleron Therapeutics Ltd. was founded in 2004, and the CEO is Nick la Thangue. | Directeur/Membre du Conseil | - | - |
Oxtex Ltd.
Oxtex Ltd. Medical SpecialtiesHealth Technology Oxtex Ltd. operates as an early-stage medical device company. It develops novel devices for soft tissue expansion. The firm's technology comprises implantable self-inflating tissue expanders available in sizes and shapes to suit the specific needs of the clinician and the patient. The company was founded by Jan Tadeusz Czernuszka and David Edward Jackson in May 2011 and is headquartered in Witney, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
Royaume-Uni | 7 |
Opérationnelle
Director/Board Member | 5 |
Chief Investment Officer | 1 |
Private Equity Investor | 1 |
Sectorielle
Health Technology | 4 |
Finance | 2 |
Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 6 |
---|---|
Oxford Spin-out Equity Management
Oxford Spin-out Equity Management Investment ManagersFinance Oxford Spin-out Equity Management (OSEM) is wholly-owned subsidiary of University of Oxford. The firm headquartered at UK. Since 2008, OSEM is responsible for spinout companies. | Finance |
Alcolizer Technology United Kingdom Ltd.
Alcolizer Technology United Kingdom Ltd. Medical DistributorsDistribution Services Alcolizer Technology United Kingdom Ltd. produces drug testing kits. It offers a device used in detecting whether a person in under the influence of specific drugs. The company was founded by Craig Edward Banks and Richard G. Compton on September 26, 2006 and is headquartered in Gateshead, the United Kingdom. | Distribution Services |
OBS Medical Ltd.
OBS Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom. | Electronic Technology |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Oxtex Ltd.
Oxtex Ltd. Medical SpecialtiesHealth Technology Oxtex Ltd. operates as an early-stage medical device company. It develops novel devices for soft tissue expansion. The firm's technology comprises implantable self-inflating tissue expanders available in sizes and shapes to suit the specific needs of the clinician and the patient. The company was founded by Jan Tadeusz Czernuszka and David Edward Jackson in May 2011 and is headquartered in Witney, the United Kingdom. | Health Technology |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. Celleron has deep relationships with Oxford University and is located on the Oxford Science Park. The British company focuses on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are currently in clinical trials, and they have a biomarker platform that allows them to identify responsive patients. Celleron Therapeutics Ltd. was founded in 2004, and the CEO is Nick la Thangue. | Health Technology |
- Bourse
- Insiders
- Christopher Towler
- Expérience